NCT00229684 · Interventional trial
ARMOR (Analyzing Renal Mechanisms of Creatinine Excretion in Patients On tesaglitazaR)
Overall registry status Terminated
Phase 2
Conditions Diabetes Mellitus, Type 2
Delaware Valley sites
- Research Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory